Exoatlet has announced a new stage in the democratisation of rehabilitation technologies. On Thursday 17 April, the company specialising in exoskeletons formalised a strategic partnership with Wecare Medlease. The aim: to facilitate access to its devices via rental or leasing formulas, developed by Wecare Medlease and tailored to the needs of individuals, researchers or healthcare facilities.
Long reserved for a few centres of excellence or well-funded research projects, Exoatlet’s exoskeletons are now becoming accessible to a much wider range of players: children and adults undergoing rehabilitation, researchers, healthcare professionals, specialist centres or charitable foundations. All will be able to benefit, according to their financial capabilities and clinical needs, from this cutting-edge equipment long considered out of reach.
The programme put in place--a world first--is based on a decade of technological and logistical development. It is now operational in Europe, the Middle East and Africa, with contracts lasting from one month to five years. Each beneficiary is accompanied by Exoatlet experts, from the initial assessment to training in the use of the exoskeleton, with regular follow-up throughout the period of use. “We are delighted to have found Wecare and Marian Mokos [its CEO, editor’s note] to be trusted partners and look forward to discovering the success stories of our most determined users,” said Exoatlet CEO Kate Bereziy.
The promise of Exoatlet goes far beyond simply assisting people to walk. The aim is to give people suffering from spinal cord injury, stroke, multiple sclerosis or spinal muscular atrophy a means of regaining their independence. “To get back on your feet, you have to walk,” Bereziy insists. “Regular walking prolongs life, reduces spasticity, restores sensitivity, improves digestive function, boosts morale and often enables children and adults to walk again... independently!” the company claims.
Based in Luxembourg, Seoul, Shanghai, Tokyo and the United States, Exoatlet is an international company dedicated to the design and marketing of exoskeletons, with a strong focus on medical rehabilitation. More than 250 hospitals worldwide now use their devices.
This article was originally published in .